• Launches

Eisai Launches New Insomnia Drug Dayvigo (Lemborexant) CIV in the United States as a Treatment Option for Adults With Insomnia

Tokyo, June 04, 2020: Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. has launched its in-house discovered…